Ipsen Biopharm Ltd et al v. Galderma Laboratories LP et al
Plaintiff: Ipsen Biopharm Ltd and Ipsen SA
Defendant: Galderma Research & Development LLC
Petitioner: Ipsen Pharma SAS
Respondent: Galderma Laboratories, L.P. and Galderma Research & Development, LLC
Counter Defendant: Galderma Laboratories LP
Case Number: 3:2023cv02593
Filed: November 22, 2023
Court: US District Court for the Northern District of Texas
Presiding Judge: Sidney A Fitzwater
Nature of Suit: Other Statutes: Arbitration
Cause of Action: 9 U.S.C. § 9 Motion to Confirm Arbitration Award
Jury Demanded By: None
Docket Report

This docket was last retrieved on January 19, 2024. A more recent docket listing may be available from PACER.

Date Filed Document Text
January 19, 2024 Opinion or Order Filing 30 FINAL JUDGMENT: IT IS HEREBY ORDERED that the ICC Award is CONFIRMED as a FINAL JUDGMENT of this Court against all of the Parties in its entirety. IT IS FURTHER ORDERED that the Parties shall complete the affirmative requirements of this Final Judgment listed in subsection (a) above within seven days of the entry of this Final Judgment. (Ordered by Senior Judge Sidney A Fitzwater on 1/19/2024) (kaf)
January 18, 2024 Filing 29 Joint MOTION for Judgment filed by Ipsen Biopharm Ltd, Ipsen Pharma SAS, Ipsen SA (Attachments: #1 Exhibit(s) A - proposed Final Judgment) (Wiehle, Scott)
January 5, 2024 Filing 28 CERTIFICATE OF INTERESTED PERSONS/DISCLOSURE STATEMENT by Galderma Laboratories LP, Galderma Research & Development LLC. (Clerk QC note: Affiliate entry indicated). (Fielding, Jeremy)
January 2, 2024 Filing 27 (Document Restricted) Sealed Exhibits re: #24 Answer to Complaint filed by Galderma Laboratories LP, Galderma Research & Development LLC. (sxf)
January 2, 2024 Opinion or Order Filing 26 ORDER granting #25 Motion to Seal Portions of Exhibits to its Answer. (Clerk to enter the sealed and/or ex parte document as of the date of this order.) (Ordered by Senior Judge Sidney A Fitzwater on 1/2/2024) (sxf)
December 29, 2023 Filing 25 (Document Restricted) Defendants' Unopposed Motion to Seal Portions of Exhibits to its Answer to Plaintiffs' Petition to Confirm Arbitration Award and Counterclaim (Sealed pursuant to motion to seal) filed by Galderma Laboratories LP, Galderma Research & Development LLC (Attachments: #1 Exhibit(s), #2 Exhibit(s), #3 Exhibit(s), #4 Exhibit(s), #5 Exhibit(s), #6 Exhibit(s), #7 Exhibit(s), #8 Proposed Order) (Fielding, Jeremy)
December 29, 2023 Filing 24 Defendants' ANSWER to #1 Complaint, filed by Galderma Laboratories LP, Galderma Research & Development LLC. Unless exempted, attorneys who are not admitted to practice in the Northern District of Texas must seek admission promptly. Forms and Instructions found at www.txnd.uscourts.gov, or by clicking here: # Attorney Information - Bar Membership. If admission requirements are not satisfied within 21 days, the clerk will notify the presiding judge., First COUNTERCLAIM against Galderma Laboratories LP, Galderma Research & Development LLC filed by Galderma Laboratories LP, Galderma Research & Development LLC (Attachments: #1 Exhibit(s), #2 Exhibit(s), #3 Exhibit(s), #4 Exhibit(s), #5 Exhibit(s), #6 Exhibit(s), #7 Exhibit(s)) (Fielding, Jeremy) Modified on 1/2/2024 (kaf).
December 28, 2023 Opinion or Order Filing 23 ORDER GRANTING #22 JOINT MOTION TO EXTEND DEADLINES. Proposed Scheduling Order due by 2/8/2024. (Ordered by Senior Judge Sidney A Fitzwater on 12/28/2023) (cfk)
December 28, 2023 Filing 22 Joint MOTION to Extend Time for Deadlines filed by Ipsen Biopharm Ltd, Ipsen Pharma SAS, Ipsen SA (Attachments: #1 Proposed Order) (Wiehle, Scott)
December 12, 2023 Opinion or Order Filing 21 ELECTRONIC ORDER granting #17 Application for Admission Pro Hac Vice of Pejmon Pashai. Important Reminder: Unless excused for cause, an attorney who is not an ECF user must register within 14 days of the date the attorney appears in a case pursuant to LR 5.1(f) and LCrR 49.2(g). (Ordered by Senior Judge Sidney A Fitzwater on 12/12/2023) (Senior Judge Sidney A Fitzwater)
December 12, 2023 Opinion or Order Filing 20 ELECTRONIC ORDER granting #16 Application for Admission Pro Hac Vice of Martin J. Black. Important Reminder: Unless excused for cause, an attorney who is not an ECF user must register within 14 days of the date the attorney appears in a case pursuant to LR 5.1(f) and LCrR 49.2(g). (Ordered by Senior Judge Sidney A Fitzwater on 12/12/2023) (Senior Judge Sidney A Fitzwater)
December 12, 2023 Opinion or Order Filing 19 ELECTRONIC ORDER granting #15 Application for Admission Pro Hac Vice of Katherine A. Helm. Important Reminder: Unless excused for cause, an attorney who is not an ECF user must register within 14 days of the date the attorney appears in a case pursuant to LR 5.1(f) and LCrR 49.2(g). (Ordered by Senior Judge Sidney A Fitzwater on 12/12/2023) (Senior Judge Sidney A Fitzwater)
December 11, 2023 Opinion or Order Filing 18 Order for Scheduling Order Proposal: Proposed Scheduling Order due by 1/8/2024. (Ordered by Senior Judge Sidney A Fitzwater on 12/11/2023) (oyh)
December 11, 2023 Filing 17 Application for Admission Pro Hac Vice with Certificate of Good Standing for Attorney Pejmon Pashai (Filing fee $100; Receipt number ATXNDC-14235902) filed by Ipsen Biopharm Ltd, Ipsen Pharma SAS, Ipsen SA (Wiehle, Scott)
December 11, 2023 Filing 16 Application for Admission Pro Hac Vice with Certificate of Good Standing for Attorney Martin J. Black (Filing fee $100; Receipt number ATXNDC-14235776) filed by Ipsen Biopharm Ltd, Ipsen Pharma SAS, Ipsen SA (Wiehle, Scott)
December 11, 2023 Filing 15 Application for Admission Pro Hac Vice with Certificate of Good Standing for Attorney Katherine A. Helm (Filing fee $100; Receipt number ATXNDC-14235603) filed by Ipsen Biopharm Ltd, Ipsen Pharma SAS, Ipsen SA (Wiehle, Scott)
December 6, 2023 Opinion or Order Filing 14 ORDER granting in part and denying in part #10 MOTION to Extend Time Expedited Opposed Motion to Extend Time for Defendants to Answer, Move, Or Otherwise Respond to Plaintiffs' Petition to Confirm Arbitration Award filed by Galderma Laboratories LP, Galderma Research & Development LLC. Responsive pleading due by 12/29/2023. (Ordered by Senior Judge Sidney A Fitzwater on 12/6/2023) (Senior Judge Sidney A Fitzwater)
December 5, 2023 Filing 13 RESPONSE filed by Ipsen Biopharm Ltd, Ipsen Pharma SAS, Ipsen SA re: #10 MOTION to Extend Time Expedited Opposed Motion to Extend Time for Defendants to Answer, Move, Or Otherwise Respond to Plaintiffs' Petition to Confirm Arbitration Award (Attachments: #1 Proposed Order) (Wiehle, Scott)
December 4, 2023 Filing 12 NOTICE of Attorney Appearance by Ruben Alan Garcia on behalf of Galderma Laboratories LP, Galderma Research & Development LLC. (Filer confirms contact info in ECF is current.) (Garcia, Ruben)
December 1, 2023 Opinion or Order Filing 11 ORDER: Any opposition response to defendants' #10 Expedited Opposed Motion to Extend Time for Defendants to Answer, Move, Or Otherwise Respond to Plaintiffs' Petition to Confirm Arbitration Award filed by Galderma Laboratories LP, Galderma Research & Development LLC must be filed no later than December 5, 2023 at 5:00 p.m. CST. Responses due by 12/5/2023. (Ordered by Senior Judge Sidney A Fitzwater on 12/1/2023) (Senior Judge Sidney A Fitzwater)
November 30, 2023 Filing 10 MOTION to Extend Time Expedited Opposed Motion to Extend Time for Defendants to Answer, Move, Or Otherwise Respond to Plaintiffs' Petition to Confirm Arbitration Award filed by Galderma Laboratories LP, Galderma Research & Development LLC (Attachments: #1 Proposed Order Granting Defendants' Request that Plaintiffs be Ordered to Provide an Expedited Response to the Motion to Extend, #2 Proposed Order Granting Defendants' Expedited Opposed Motion to Extend Time for Defendants to Answer, Move, Or Otherwise Respond to Plaintiffs' Petition to Confirm Arbitration Award)Attorney Jeremy A Fielding added to party Galderma Laboratories LP(pty:dft), Attorney Jeremy A Fielding added to party Galderma Research & Development LLC(pty:dft) (Fielding, Jeremy)
November 30, 2023 Filing 9 SUMMONS Returned Executed as to Galderma Research & Development LLC ; served on 11/28/2023. (Wiehle, Scott)
November 30, 2023 Filing 8 SUMMONS Returned Executed as to Galderma Laboratories LP ; served on 11/29/2023. (Wiehle, Scott)
November 27, 2023 Filing 7 Summons Issued as to Galderma Laboratories LP, Galderma Research & Development LLC. (Attachments: #1 Additional Page(s)) (ndt)
November 22, 2023 Filing 6 New Case Notes: A filing fee has been paid. Pursuant to Misc. Order 6, Plaintiff is provided the Notice of Right to Consent to Proceed Before A U.S. Magistrate Judge (Judge Rutherford). Clerk to provide copy to plaintiff if not received electronically. (ndt)
November 22, 2023 Filing 5 Request for Clerk to issue Summons for Galderma Research & Development, LLC filed by Ipsen Biopharm Ltd, Ipsen Pharma SAS, Ipsen SA. (Wiehle, Scott)
November 22, 2023 Filing 4 Request for Clerk to issue Summons for Galderma Laboratories, L.P. filed by Ipsen Biopharm Ltd, Ipsen Pharma SAS, Ipsen SA. (Wiehle, Scott)
November 22, 2023 Filing 3 NOTICE of Related Case filed by Ipsen Biopharm Ltd, Ipsen Pharma SAS, Ipsen SA (Wiehle, Scott)
November 22, 2023 Filing 2 CERTIFICATE OF INTERESTED PERSONS/DISCLOSURE STATEMENT by Ipsen Biopharm Ltd, Ipsen Pharma SAS, Ipsen SA. (Clerk QC note: No affiliate entered in ECF). (Wiehle, Scott)
November 22, 2023 Filing 1 COMPLAINT against Galderma Laboratories, L.P., Galderma Research & Development, LLC filed by Ipsen Pharma SAS, Ipsen SA, Ipsen Biopharm Ltd. (Filing fee $402; Receipt number ATXNDC-14193684) Plaintiff will submit summons(es) for issuance. In each Notice of Electronic Filing, the judge assignment is indicated, and a link to the # Judges Copy Requirements and # Judge Specific Requirements is provided. The court reminds the filer that any required copy of this and future documents must be delivered to the judge, in the manner prescribed, within three business days of filing. Unless exempted, attorneys who are not admitted to practice in the Northern District of Texas must seek admission promptly. Forms, instructions, and exemption information may be found at www.txnd.uscourts.gov, or by clicking here: # Attorney Information - Bar Membership. If admission requirements are not satisfied within 21 days, the clerk will notify the presiding judge. (Attachments: #1 Exhibit(s) A, #2 Cover Sheet) (Wiehle, Scott)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Texas Northern District Court's Electronic Court Filings (ECF) System

Search for this case: Ipsen Biopharm Ltd et al v. Galderma Laboratories LP et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Ipsen Biopharm Ltd
Represented By: Chad Arnette
Represented By: Katherine Ann Helm
Represented By: Pejmon Pashai
Represented By: Scott R Wiehle
Represented By: Martin J Black
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Ipsen SA
Represented By: Chad Arnette
Represented By: Katherine Ann Helm
Represented By: Pejmon Pashai
Represented By: Scott R Wiehle
Represented By: Martin J Black
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Petitioner: Ipsen Pharma SAS
Represented By: Chad Arnette
Represented By: Katherine Ann Helm
Represented By: Pejmon Pashai
Represented By: Scott R Wiehle
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Respondent: Galderma Laboratories, L.P.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Respondent: Galderma Research & Development, LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: Galderma Laboratories LP
Represented By: Jeremy A Fielding
Represented By: Ruben Alan Garcia
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Galderma Research & Development LLC
Represented By: Jeremy A Fielding
Represented By: Ruben Alan Garcia
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?